Veronika Shabanova, PhD
Associate Professor of Pediatrics (General Pediatrics) and of BiostatisticsDownloadHi-Res Photo
Cards
Appointments
General Pediatrics
Primary
Biostatistics
Secondary
Additional Titles
Biostatistician
Contact Info
Appointments
General Pediatrics
Primary
Biostatistics
Secondary
Additional Titles
Biostatistician
Contact Info
Appointments
General Pediatrics
Primary
Biostatistics
Secondary
Additional Titles
Biostatistician
Contact Info
About
Copy Link
Titles
Associate Professor of Pediatrics (General Pediatrics) and of Biostatistics
Biostatistician
Biography
Dr. Shabanova is a faculty member in the department of Pediatrics and Department of Biostatistics at Yale University. Prior to that she was one of the senior biostatisticians at the Yale Center for Analytical Sciences (YCAS). With over 20 years of experience as a researcher and statistician in academia and industry, she acquired expertise in statistical and epidemiological methods related to a variety of studies, including development of testable hypotheses, selection of study designs, randomization algorithms, and analytical considerations that correspond to particular study designs. Her statistical expertise are in survival and multi-level/longitudinal techniques. Dr. Shabanova's work has primarily been focused on collaborations with other researchers, including physicians and academicians, in the field of maternal and child health at Yale.
Last Updated on April 07, 2025.
Appointments
General Pediatrics
Associate Professor on TermPrimaryBiostatistics
Associate Professor on TermSecondary
Other Departments & Organizations
Education & Training
- PhD
- Yale University, Biostatistics (2017)
- MPH
- Yale University (1999)
- BS
- Kansas State University, Biology (1997)
Research
Copy Link
Overview
Medical Research Interests
Clinical Trials as Topic; Cystic Fibrosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; HIV; Intensive Care, Neonatal; Lactation; Metabolic Diseases; Neurology; Pediatrics; Statistics as Topic; Venous Thrombosis
ORCID
0000-0001-8090-9238
Research at a Glance
Yale Co-Authors
Frequent collaborators of Veronika Shabanova's published research.
Publications Timeline
A big-picture view of Veronika Shabanova's research output by year.
Research Interests
Research topics Veronika Shabanova is interested in exploring.
Sarah N. Taylor, MD, MSCR
Fangyong Li, MS, MPH
Melissa Langhan, MD, MHS
Sarah McCollum
Elijah Paintsil, FAAP, MD
Matthew Bizzarro, MD
139Publications
3,966Citations
Venous Thrombosis
Pediatrics
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Intensive Care, Neonatal
Cystic Fibrosis
Publications
2025
Stratification Bias in Associations Between Prepregnancy BMI and Neonatal Outcomes Following Extremely Preterm Birth
Wu B, Hawley N, Taylor S, Shabanova V. Stratification Bias in Associations Between Prepregnancy BMI and Neonatal Outcomes Following Extremely Preterm Birth. Obesity 2025 PMID: 41349962, DOI: 10.1002/oby.70092.Peer-Reviewed Original ResearchChanges in caregiver psychosocial factors known to affect pediatric HIV disclosure: the Sankofa clinical trial experience in Ghana (2013–2023)
Afrane A, Bobbala A, Martyn-Dickens C, Renner L, Antwi S, Kusah J, Amissah K, Quaye D, Bosomtwe D, Gan G, Parziale S, Reynolds N, Paintsil E, Shabanova V, Team O. Changes in caregiver psychosocial factors known to affect pediatric HIV disclosure: the Sankofa clinical trial experience in Ghana (2013–2023). AIDS Care 2025, ahead-of-print: 1-16. PMID: 41330401, DOI: 10.1080/09540121.2025.2594607.Peer-Reviewed Original ResearchConceptsPediatric HIV disclosureIllness perceptionsHIV disclosureHIV knowledgePsychosocial domainsSocial supportHIV statusCaregiver psychosocial factorsCaregiver-related factorsChild's HIV statusChildren Aged 7Earning higher incomeMultivariate linear regressionCaregiver characteristicsHIV stigmaHigh stigmaPsychosocial factorsCaregiversStructured questionnaireHigher incomeBaseline dataStigmaAged 7Younger ageHIVScale-up of a paediatric HIV disclosure intervention in Ghana using a stepped wedge cluster randomised trial design: Sankofa 2 protocol and implementation
Reynolds N, Shabanova V, Renner L, Antwi S, Addo S, Enimil A, Lartey M, Gan G, Parziale S, Amissah K, Kusah J, Ofori-Atta A, Slade E, Agyarko-Poku T, Paintsil E. Scale-up of a paediatric HIV disclosure intervention in Ghana using a stepped wedge cluster randomised trial design: Sankofa 2 protocol and implementation. BMJ Open 2025, 15: e099681. PMID: 41238360, PMCID: PMC12625916, DOI: 10.1136/bmjopen-2025-099681.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsHIV disclosure interventionsDisclosure interventionGhana Health Service Ethical Review CommitteeStepped-wedge cluster randomised trialCluster randomised trial designCluster randomised trialReview CommitteeRandomised trial designHealth benefitsCaregiver-child dyadsPeer-reviewed journalsCaregiver participationProtocol Review CommitteeYale SchoolEthics Review CommitteeHuman Investigation CommitteeEffective interventionsHealthcare workersHIV statusPaediatric clinicsCaregiversEthical clearanceFollow-up studyWritten Informed ConsentEvaluation of effectivenessPlatelet-related biomarkers and catheter-associated thrombosis in critically ill children: An exploratory study
Regmi H, Li I, Prozora S, Sharda A, Shabanova V, Faustino E, Investigators C. Platelet-related biomarkers and catheter-associated thrombosis in critically ill children: An exploratory study. Thrombosis Research 2025, 256: 109534. PMID: 41223722, PMCID: PMC12712714, DOI: 10.1016/j.thromres.2025.109534.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsCatheter-associated deep venous thrombosisClinically Relevant BleedingCritically Ill ChildrenCentral venous catheterProphylactic enoxaparinPlatelet factor 4P-selectinIL-6Ill childrenTNF-aPlatelet activationBiomarkers of platelet activationCatheter-associated thrombosisDeep venous thrombosisFactor 4Platelet-poor plasmaSeverity of illnessRelevant bleedingPharmacological prophylaxisPlatelet countVenous cathetersMulticenter studyVenous thrombosisIL-2IL-1BPrevalence and factors associated with metabolic syndrome among ART Naïve people living with HIV in Accra, Ghana: a multicenter cross-sectional study
Odikro M, Torpey K, Lartey M, Agyabeng K, Shabanova V, Ganu V, Painstil E, Kenu E. Prevalence and factors associated with metabolic syndrome among ART Naïve people living with HIV in Accra, Ghana: a multicenter cross-sectional study. AIDS Research And Therapy 2025, 22: 83. PMID: 40855323, PMCID: PMC12376448, DOI: 10.1186/s12981-025-00783-z.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsART-naive PLWHAdjusted odds ratiosCross-sectional studyHigh density lipoprotein cholesterolMetS prevalenceWorld Health OrganizationFactors associated with metabolic syndromeFactors associated with MetSMulti-centric cross-sectional studyOdds of MetSRoutine screeningMulticenter cross-sectional studyAge of participantsMetabolic syndromeModified World Health OrganizationConsistent with known risk factorsPre-antiretroviral therapyLipoprotein cholesterolRaised blood pressureImpaired fasting glucoseKnown Risk FactorsSTEPS questionnaireCardiometabolic illnessHigh-density lipoprotein cholesterolART-naive peopleWait-List Controlled Pilot Trial of a Preventive Mental Health Intervention for Refugee Youth
Rosenberg J, McDonough Ryan P, Schaffer R, O’Brien C, Shabanova V, Ganjavi F, Sharifi M. Wait-List Controlled Pilot Trial of a Preventive Mental Health Intervention for Refugee Youth. Journal Of Immigrant And Minority Health 2025, 27: 723-733. PMID: 40783623, DOI: 10.1007/s10903-025-01739-1.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsUS populationUnique mental health needsPreventive mental health interventionsWait-list controlled trialWait-list controlled pilot trialMental health interventionsMental health needsControlled Pilot TrialPreventive mental healthStrengths-based interventionsQuality of lifeCOVID-19 knowledgePediatric QualityHealth interventionsHealth needsWellness interventionsMental healthEmpowering interventionsInterdisciplinary teamPreliminary efficacyChildren’s emotional awarenessExpressed satisfactionFeeling scoresPilot trialEmotional awarenessSWCRTsimulator: A simulation-based platform for power estimation in stepped wedge cluster randomized trials with interval-censored outcomes
Lu X, Kennedy-Shaffer L, Shabanova V. SWCRTsimulator: A simulation-based platform for power estimation in stepped wedge cluster randomized trials with interval-censored outcomes. SoftwareX 2025, 31: 102288. PMID: 41036414, PMCID: PMC12483528, DOI: 10.1016/j.softx.2025.102288.Peer-Reviewed Original ResearchAltmetricConceptsStepped wedge cluster randomized trialCluster randomized trialStudy design featuresHIV disclosure interventionsInterval-censored outcomesTime-to-event outcomesEvaluation of interventionsRandomized trialsStatistical power estimatesDisclosure interventionIntervention effectsSample sizeApproximation methodPublic healthMonte Carlo simulationsClosed-form solutionInterventionClinical researchCarlo simulationsEstimationTrialsOutcomesPower estimationMaternal Obesity and Neonatal Death in Preterm US Pacific Islander Neonates Using 2 Analytic Approaches
Wu B, Taylor S, Hawley N, Shabanova V. Maternal Obesity and Neonatal Death in Preterm US Pacific Islander Neonates Using 2 Analytic Approaches. JAMA Network Open 2025, 8: e2528924. PMID: 40856998, PMCID: PMC12381668, DOI: 10.1001/jamanetworkopen.2025.28924.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsFetuses-at-risk approachFetuses-at-riskPrepregnancy body mass indexBody mass indexPreterm birthGestational ageNeonatal deathPacific Islander individualsObesity class ICohort studyWeeks GAPrepregnancy obesityStratification biasIslander individualsNational Center for Health StatisticsRate of neonatal deathPopulation-based cohort studyCenter for Health StatisticsClass IDegree of prematurityMother-neonate dyadsPrevalence of obesityCox proportional hazards modelsNeonatal mortality ratePreterm birth prevalenceAlterations in lipid profiles in children with perinatally acquired HIV infection living in Ghana: A cross-sectional study
Ayanful-Torgby R, Shabanova V, Essuman A, Boafo E, Amoah L, Paintsil E. Alterations in lipid profiles in children with perinatally acquired HIV infection living in Ghana: A cross-sectional study. PLOS ONE 2025, 20: e0318314. PMID: 40674377, PMCID: PMC12270137, DOI: 10.1371/journal.pone.0318314.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsPrevalence of dyslipidemiaAntiretroviral therapyLipid profileLDL-CTotal cholesterolCross-sectional studyDyslipidemia prevalenceLipoprotein cholesterolAbnormal LDL-C levelsMonitoring of lipid profileHormonal changesEarly onset cardiovascular diseaseCardiovascular diseaseLifelong antiretroviral therapyHigh-density lipoprotein cholesterolLow-density lipoprotein cholesterolLDL-C levelsElevated total cholesterolConfirmatory investigationsEffects of ageLipid profile levelsAge groupsLevels of TCAge group 6Children Aged 6Prevalence and phenotype of food allergy in children with cystic fibrosis
Nguyen H, Shabanova V, McCollum S, Polk B, Lee T, Whittington K, Cunha P, Bruscia E, Egan M, Emmenegger M, Leeds S. Prevalence and phenotype of food allergy in children with cystic fibrosis. Annals Of Allergy Asthma & Immunology 2025, 135: 419-424. PMID: 40550267, DOI: 10.1016/j.anai.2025.06.024.Peer-Reviewed Original ResearchAltmetricConceptsCystic fibrosisCF patientsFood allergyUS pediatric populationElectronic medical recordsPediatric populationPhenotypes of food allergyRetrospective pediatric cohort studyPrevalence of FAFA prevalenceCystic Fibrosis Foundation RegistryMale CF patientsUnited StatesPediatric CF patientsPancreatic enzyme replacementPediatric cohort studyIgE-mediated FACohort studyEstimated prevalenceInclusion criteriaMedical informationDevelopment of FAMedical recordsFA diagnosisPrevalence
News & Links
Copy Link
News
- May 05, 2025
Phage Therapy May Treat Drug Resistance in Patients With Cystic Fibrosis, Study Finds
- February 28, 2024
Yale Pediatrics Poster Presenters at PAS 2024
- May 15, 2023
Study Identifies Bereaved Parents’ Medical Priorities for Children With Advanced Cancer
- April 24, 2023
New way of measuring neonatal mortality uncovers 'paradoxical' racial disparity
Get In Touch
Copy Link